VITILIGO

This study tests an experimental drug called LY4005130 in 60 adults with non-segmental vitiligo, a condition that causes white patches on the skin. Participants will receive either the drug or a placebo through an IV over 24 weeks. The goal is to see if the drug can safely help b…

This study tests whether a gel called CGB-600 can safely reduce white patches caused by vitiligo on the face and neck. About 36 adults aged 18 to 60 will apply the gel twice daily for 24 weeks. Researchers will compare the gel to a placebo to see if it helps restore skin color.

This study tests a procedure where a person's own skin cells are transplanted onto white patches caused by vitiligo. The goal is to see how well and how long the color returns. The trial involves 30 people with stable vitiligo who have not responded to other treatments.

This study tests a new medicine called FB102 for people with non-segmental vitiligo, a condition that causes white patches on the skin. The trial will include 64 adults and aims to see if FB102 is safe and can help restore skin color on the face. Participants will receive either …

This study tests whether using ultrasound (phonophoresis) to push betamethasone cream into the skin can help control vitiligo, a condition that causes white patches. Researchers will enroll 60 adults with vitiligo who are otherwise healthy. The goal is to see if this method reduc…

This study is for people with vitiligo, a skin condition that causes white patches. Researchers want to understand what factors make a cream called ruxolitinib work better or worse. They will follow 170 people aged 12 and older who have vitiligo on less than 10% of their body. Th…

This study tests a new type of cream that fizzes when applied to the skin. The cream contains 5-fluorouracil, a medicine that may help bring back skin color in people with stable vitiligo. About 60 people aged 10 and older with patches that haven't changed for at least a year wil…

This study tests whether needling or microneedling, followed by narrowband UVB light, works better to bring back skin color in people with stable non-segmental vitiligo. Eighty adults aged 15–60 with vitiligo for over a year will receive one of the two treatments. The main goal i…

This study tests whether adding methotrexate (a medication) to a skin cell transplant procedure helps restore color better than the procedure alone. Twenty adults with stable, hard-to-treat vitiligo on elbows and knees will be split into two groups: one gets methotrexate for 6 mo…

This early-phase study tests a new drug, DR-01, in 80 adults with alopecia areata (patchy hair loss) or vitiligo (white patches on skin). The main goals are to check safety and see if the drug can improve hair regrowth or skin color. Participants are randomly assigned to differen…

This study is testing if a procedure using tiny needles (microneedling) with a drug called 5FU works better than a strong steroid cream to bring back skin color in small patches of vitiligo. Researchers will compare the two treatments in 40 people with stable vitiligo over 12 wee…